Role of T cells in non-immediate drug allergy reactions. Issue 4 (August 2019)

• Record Type: Journal Article
• Authors: Gómez, E.; Ruano, M.; Somoza, M.L.; Fernández, J.; Blanca-López, N.
• Is Part Of: Current opinion in allergy and clinical immunology. Volume 19:Issue 4(2019:Aug.)
• Publication Date: 2019-08
• Subjects: allergy -- drug -- nonimmediate reactions -- T cells; Allergy -- Periodicals; Clinical immunology -- Periodicals; Hypersensitivity; Immunity; Immune System Diseases; Allergy and Immunology; 616.079
• DOI: 10.1097/ACI.0000000000000547
• Languages: English
• ISSNs: 1528-4050

Abstract

Abstract : Purpose of review: Nonimmediate drug hypersensitivity reactions (NI-DHR) constitute the most complex group of drug allergy, with many drugs involved. Both parent drugs and their reactive metabolites can be implicated. Although with some drugs the number of metabolites is limited, with others it is quite extensive and many still remain to be identified. The diagnostic approaches are insufficient for the diagnosis and realistic approaches that reproduce the pathological response are lacking. Recent findings: A wider view has now been considered, with the inclusion of several mechanisms that may contribute to drug hypersensitivity reactions (DHR): the classical hapten hypothesis, the danger signal and the pharmacological interaction. Monitoring the acute response provides relevant information about the mechanisms involved, with the identification of a large number of genes that can be over-expressed or under-expressed in the acute phase of the response. Assessment of risk of developing reactions can be verified by HLA associations. Summary: Further knowledge of these NI-DHR, including molecular genetics and transcriptomic analysis, has enabled a better understanding and management of these reactions.